Literature DB >> 31337420

Correction to: PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma.

Ki Hyung Kim1, Kyung Un Choi2, Ahrong Kim2, So Jung Lee2, Jung Hee Lee3,4, Dong Soo Suh1, Byung-Su Kwon1, Chungsu Hwang5,6.   

Abstract

Following publication of the original article [1], the authors opted to correct the incorrect e-mail address of the corresponding author from 82-55-360-1850chungsu1982@gmail.com to chungsu1982@gmail.com , grant in the Acknowledgements section and Author details. Below are the updated version of the Acknowledgements and Author details.

Entities:  

Year:  2019        PMID： 31337420      PMCID： PMC6647086          DOI： 10.1186/s13048-019-0540-2

Source DB:  PubMed          Journal:  J Ovarian Res        ISSN： 1757-2215            Impact factor:   4.234


Correction to: J Ovarian Res (2019) 12:56 https://doi.org/10.1186/s13048-019-0526-0 Following publication of the original article [1], the authors opted to correct the incorrect e-mail address of the corresponding author from 82-55-360-1850chungsu1982@gmail.com to chungsu1982@gmail.com, grant in the Acknowledgements section and Author details. Below are the updated version of the Acknowledgements and Author details.
  1 in total

1.  PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma.

Authors:  Ki Hyung Kim; Kyung Un Choi; Ahrong Kim; So Jung Lee; Jung Hee Lee; Dong Soo Suh; Byung-Su Kwon; Chungsu Hwang
Journal:  J Ovarian Res       Date:  2019-06-17       Impact factor: 4.234
  1 in total
  1 in total

1.  Prognostic and Clinical Value of Interleukin 6 and CD45+CD14+ Inflammatory Cells with PD-L1+/PD-L2+ Expression in Patients with Different Manifestation of Ovarian Cancer.

Authors:  Iwona Wertel; Dorota Suszczyk; Anna Pawłowska; Monika Bilska; Agata Chudzik; Wiktoria Skiba; Roman Paduch; Jan Kotarski
Journal:  J Immunol Res       Date:  2020-09-30       Impact factor: 4.818
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.